Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam

Performance Evaluation of Analgesia Nociception Index (ANI) in Patients Under General Anaesthesia With Remimazolam: a Prospective Observational Study

The purpose of this study is to determine whether Analgesia Nociception Index (ANI) can effectively reduce the dose of opioid in patients who underwent general anesthesia using remimazolam.

Inclusion Criteria:

Patients

• aged 20-79 years under general anaesthesia with remimazolam
• scheduled to undergo robotic surgery
• in American Society of Anesthesiologists physical class 1, 2 or 3
• voluntarily agree in writing to participate in this clinical study

Exclusion Criteria:

• Conditions affecting the autonomic nervous system
• other conditions or disease that may cause acute or chronic pain
• the NRS before induction of anesthesia is 1 or over
• When taking medications that may affect the autonomic nervous system
• In other cases where the investigator deems the subject unsuitable for this trial